Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

Chronic obstructive pulmonary disease is a serious, progressive illness that hits the homeless and underinsured the hardest.

Many people with COPD can control their symptoms by using inhaled medicines each day. But inhaled medicines may not offer enough relief for people who also have high levels of a type of white ...

Winter is prime time for COPD. You can’t get rid of the disease, but treatment can improve quality of life.Key takeaways:COPD ...

When you have COPD, your lifestyle has a major impact on the severity and progression of your illness. Every treatment plan should start with healthy lifestyle changes. Medications alone should not be ...

Inhaled glucocorticoids may or may not be recommended. While they reduce the risk of exacerbations, they also increase the risk a person will develop pneumonia. They are likely helpful for people who ...

Fluticasone is a prescription corticosteroid for long-term treatment of respiratory disorders, such as asthma and COPD. It is not supposed to relieve sudden breathing problems, so it won’t replace a ...

When you have COPD, your lifestyle has a major impact on the severity and progression of your illness. Every treatment plan ...